H. Ismail, F. A. Alzubaidi, and E. N. Oubaid, “Targeting the IL-33/ST2 signalling pathway as a therapeutic strategy for the treatment of multiple inflammatory diseases”, P, vol. 37, no. 2S, Oct. 2025.